Status:

UNKNOWN

Fetoscopic Selective Laser Photocoagulation in Twin-Twin Transfusion Syndrome

Lead Sponsor:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborating Sponsors:

Children's Hospital Medical Center, Cincinnati

Conditions:

Twin to Twin Transfusion Syndrome

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

This is a study to compare two treatments (amnioreduction vs. selective fetoscopic laser photocoagulation \[SFLP\]) in patients with severe twin to twin transfusion syndrome.

Detailed Description

We hypothesize that treatment of the underlying chorioangiopagus by selective fetoscopic laser photocoagulation will not only improve the survival of twins but will reduce the incidence of neurologic,...

Eligibility Criteria

Inclusion

  • Both twins are alive
  • TTTS diagnosed prior to 22 weeks gestation
  • Monochorionic diamniotic gestation
  • Like sex twins
  • Single placental mass
  • Thin intertwin membrane
  • Oligohydramnios in donor twin (deepest vertical pocket of ≤ 2 cm)
  • Polyhydramnios with deepest vertical pocket of \> 8 cm with or without Doppler or echocardiographic changes in the recipient twin (deepest vertical pocket of \> 6 cm if previous amnioreduction)
  • Decompressed bladder in donor not seen to fill during the ultrasound examination (stage II, III, or IV), unless Doppler velocimetry changes (absent end-diastolic umbilical artery flow, abnormal ductus venosus waveform), and/or echocardiographic changes (valvular insufficiency, ventricular hypertrophy) are already present
  • No associated structural abnormalities
  • No sonographic evidence of CNS injury at time of entry
  • No preterm labor
  • No maternal medical contraindication to anesthesia or surgery

Exclusion

  • Failure to meet all inclusion criteria
  • TTTS presenting after 22 weeks gestation
  • Randomization after 24 weeks gestation
  • Cervical length \< 2.0 cm post initial
  • Presence of cervical cerclage
  • Uterine anomaly
  • Refusal to accept randomization
  • Unable to pursue prenatal care at an approved center coordinated by one of the participating institutions
  • Unable to pursue postnatal evaluation at a NICHD Neonatal Research Network Institution

Key Trial Info

Start Date :

March 1 2002

Trial Type :

INTERVENTIONAL

End Date :

May 1 2007

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT00345852

Start Date

March 1 2002

End Date

May 1 2007

Last Update

June 29 2007

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

University of California-San Francisco

San Francisco, California, United States, 94143

2

Evanston Northwestern Healthcare

Evanston, Illinois, United States, 60201

3

New York University School of Medicine

New York, New York, United States, 10016

4

Columbia-Presbyterian Medical Center

New York, New York, United States, 10032